MASS
908 Devices Inc.NASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
12.68
PEG
0.10
P/B
1.73
P/S
4.56
EV/EBITDA
-6.24
DCF Value
$-7.75
FCF Yield
-9.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
50.6%
Operating Margin
-70.1%
Net Margin
34.7%
ROE
13.3%
ROA
10.3%
ROIC
-22.8%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $17.4M | $4.2M | $0.10 |
| FY 2025 | $56.2M | $19.5M | $0.54 |
| Q3 2025 | $14.0M | $-15.0M | $-0.41 |
| Q2 2025 | $13.0M | $-13.3M | $-0.37 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
0.53
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.